Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
EZSCAN is a device that can detect the risk of diabetes
EZSCAN is a medical device for the early detection of peripheral autonomic neuropathies to identify people at increased risk of diabetes (pre-diabetes included).
This is an alternative method of screening to optimize prevention and management of diabetes risk.
EZSCAN RESULT SCREEN
A risk score according to measured conductances and patient data (hight, weight, age) is calculated:
- Green : no risk
- Yellow: moderate risk
- Orange: high risk
- Red: very high risk